Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Sousa, Josane F ^a   Espreafico, Enilza M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; VITRONECTIN RECEPTOR; HLA DR ANTIGEN; HLA-DRA; KISS1 PROTEIN, HUMAN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL GROWTH; CHROMOSOME 1; CLONE; CONTROLLED STUDY; DNA PACKAGING; DNA REPAIR; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE SEQUENCE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTASIS; NORTHERN BLOTTING; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UNINDEXED SEQUENCE; CANCER STAGING; CELL CLONE; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CLONE CELLS; DISEASE PROGRESSION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HLA-DR ANTIGENS; HUMANS; INTEGRIN ALPHAVBETA3; MELANOMA; NEOPLASM STAGING; RHO GTP-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 40949141913     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-19     Document Type: Article

References (94)

1. Grossman D Altieri DC Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets Cancer Metastasis Rev 2001, 20(1-2):3-11 11831644
2. Helmbach H Rossmann E Kern MA Schadendorf D Drug-resistance in human melanoma Int J Cancer 2001, 93(5):617-622 11477569
3. Soengas MS Lowe SW Apoptosis and melanoma chemoresistance Oncogene 2003, 22(20):3138-3151 12789290
4. Meier F Satyamoorthy K Nesbit M Hsu MY Schittek B Garbe C Herlyn M Molecular events in melanoma development and progression Front Biosci 1998, 3:D1005-10 9740553
5. Kath R Jambrosic JA Holland L Rodeck U Herlyn M Development of invasive and growth factor-independent cell variants from primary human melanomas Cancer Res 1991, 51(8):2205-2211 2009539
6. Herlyn M Thurin J Balaban G Bennicelli JL Herlyn D Elder DE Bondi E Guerry D Nowell P Clark WH Characteristics of cultured human melanocytes isolated from different stages of tumor progression Cancer Res 1985, 45(11 Pt 2):5670-5676 4053039
7. Hsu MY Elder, D. E., Herlyn, M. Melanoma: The Wistar Melanoma (WM) Cell Lines Human Cell Cultures Kluwer Academic Publishers 1999, 1:259-274
8. Hsu MY Shih DT Meier FE Van Belle P Hsu JY Elder DE Buck CA Herlyn M Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma Am J Pathol 1998, 153(5):1435-1442 1853416 9811334
9. Herlyn M Balaban G Bennicelli J Guerry D Halaban R Herlyn D Elder DE Maul GG Steplewski Z Nowell PC Primary melanoma cells of the vertical growth phase: Similarities to metastatic cells J Natl Cancer Inst 1985, 74(2):283-289 3856042
10. Liu ZJ Xiao M Balint K Smalley KS Brafford P Qiu R Pinnix CC Li X Herlyn M Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression Cancer Res 2006, 66(8):4182-4190 16618740
11. Ryu B Kim DS Deluca AM Alani RM Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression PLoS ONE 2007, 2(7):e594 1895889 17611626
12. van't Veer LJ Dai H van de Vijver MJ He YD Hart AA Mao M Peterse HL van der Kooy K Marton MJ Witteveen AT Schreiber GJ Kerkhoven RM Roberts C Linsley PS Bernards R Friend SH Gene expression profiling predicts clinical outcome of breast cancer Nature 2002 415(6871):530-536 11823860
13. Bernards R Weinberg RA A progression puzzle Nature 2002, 418(6900):823 12192390
14. Gupta PB Kuperwasser C Brunet JP Ramaswamy S Kuo WL Gray JW Naber SP Weinberg RA The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nat Genet 2005, 37(10):1047-1054 1694635 16142232
15. Abramova L Slingluff CL Jr. Patterson JW Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize J Cutan Pathol 2002, 29(7):407-414 12139635
16. Haqq C Nosrati M Sudilovsky D Crothers J Khodabakhsh D Pulliam BL Federman S Miller JR 3rd Allen RE Singer MI Leong SP Ljung BM Sagebiel RW Kashani-Sabet M The gene expression signatures of melanoma progression Proc Natl Acad Sci U S A 2005, 102(17):6092-6097 1087936 15833814
17. Van Belle PA Elenitsas R Satyamoorthy K Wolfe JT Guerry D Schuchter L Van Belle TJ Albelda S Tahin P Herlyn M Elder DE Progression-related expression of beta3 integrin in melanomas and nevi Hum Pathol 1999, 30(5):562-567 10333228
18. Petitclerc E Stromblad S von Schalscha TL Mitjans F Piulats J Montgomery AM Cheresh DA Brooks PC Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival Cancer Res 1999, 59(11):2724-2730 10363998
19. Sturm RA Satyamoorthy K Meier F Gardiner BB Smit DJ Vaidya B Herlyn M Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells Cancer Res 2002, 62(1):226-232 11782382
20. Lee JH Miele ME Hicks DJ Phillips KK Trent JM Weissman BE Welch DR KiSS-1, a novel human malignant melanoma metastasis-suppressor gene J Natl Cancer Inst 1996, 88(23):1731-1737 8944003
21. Shirasaki F Takata M Hatta N Takehara K Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23 Cancer Res 2001, 61(20):7422-7425 11606374
22. Kotani M Detheux M Vandenbogaerde A Communi D Vanderwinden JM Le Poul E Brezillon S Tyldesley R Suarez-Huerta N Vandeput F Blanpain C Schiffmann SN Vassart G Parmentier M The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54 J Biol Chem 2001, 276(37):34631-34636 11457843
23. Ohtaki T Shintani Y Honda S Matsumoto H Hori A Kanehashi K Terao Y Kumano S Takatsu Y Masuda Y Ishibashi Y Watanabe T Asada M Yamada T Suenaga M Kitada C Usuki S Kurokawa T Onda H Nishimura O Fujino M Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor Nature 2001, 411(6837):613-617 11385580
24. Lee JH Welch DR Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1 Cancer Res 1997, 57(12):2384-2387 9192814
25. Masui T Doi R Mori T Toyoda E Koizumi M Kami K Ito D Peiper SC Broach JR Oishi S Niida A Fujii N Imamura M Metastin and its variant forms suppress migration of pancreatic cancer cells Biochem Biophys Res Commun 2004, 315(1):85-92 15013429
26. Sanchez-Carbayo M Capodieci P Cordon-Cardo C Tumor suppressor role of KiSS-1 in bladder cancer: Loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome Am J Pathol 2003, 162(2):609-617 1851149 12547718
27. Clark EA Golub TR Lander ES Hynes RO Genomic analysis of metastasis reveals an essential role for RhoC Nature 2000, 406(6795):532-535 10952316
28. Strausberg RL Simpson AJ Wooster R Sequence-based cancer genomics: progress, lessons and opportunities Nat Rev Genet 2003, 4(6):409-418 12776211
29. Diatchenko L Lau YF Campbell AP Chenchik A Moqadam F Huang B Lukyanov S Lukyanov K Gurskaya N Sverdlov ED Siebert PD Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries Proc Natl Acad Sci U S A 1996, 93(12):6025-6030 39182 8650213
30. Cao W Epstein C Liu H DeLoughery C Ge N Lin J Diao R Cao H Long F Zhang X Chen Y Wright PS Busch S Wenck M Wong K Saltzman AG Tang Z Liu L Zilberstein A Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: A case study BMC Genomics 2004, 5(1):26 415544 15113399
31. Silva WA Jr. Costa MC Valente V Sousa JF Paco-Larson ML Espreafico EM Camargo SS Monteiro E Holanda AJ Zago MA Simpson AJ Dias Neto E PCR template preparation for capillary DNA sequencing Biotechniques 2001, 30(3):537-540 11256382 11256382
32. GenBank Website http://www.ncbi.nlm.nih.gov/Genbank/index.html
33. Gene Ontology Tree Machine Website http://bioinfo.vanderbilt.edu/gotm
34. BLAT Tool Website http://genome.ucsc.edu/cgi-bin/hgBlat
35. WebGestalt Website http://bioinfo.vanderbilt.edu/webgestalt
36. Church GM Gilbert W Genomic sequencing Proc Natl Acad Sci U S A 1984, 81(7):1991-1995 345422 6326095
37. PNAS Website http://www.pnas.org
38. Tusher VG Tibshirani R Chu G Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci U S A 2001, 98(9):5116-5121 33173 11309499
39. Mueller A O'Rourke J Grimm J Guillemin K Dixon MF Lee A Falkow S Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma Proc Natl Acad Sci U S A 2003, 100(3):1292-1297 298766 12552104
40. Eisen MB Spellman PT Brown PO Botstein D Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci U S A 1998, 95(25):14863-14868 24541 9843981
41. Woods D Cherwinski H Venetsanakos E Bhat A Gysin S Humbert M Bray PF Saylor VL McMahon M Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway Mol Cell Biol 2001, 21(9):3192-3205 86954 11287623
42. Yang J Price MA Neudauer CL Wilson C Ferrone S Xia H Iida J Simpson MA McCarthy JB Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms J Cell Biol 2004, 165(6):881-891 2172406 15210734
43. Tralhao JG Schaefer L Micegova M Evaristo C Schonherr E Kayal S Veiga-Fernandes H Danel C Iozzo RV Kresse H Lemarchand P In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer FASEB J 2003, 17(3):464-466 12631584
44. Bartkova J Horejsi Z Koed K Kramer A Tort F Zieger K Guldberg P Sehested M Nesland JM Lukas C Orntoft T Lukas J Bartek J DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 2005, 434(7035):864-870 15829956
45. Gorgoulis VG Vassiliou LV Karakaidos P Zacharatos P Kotsinas A Liloglou T Venere M Ditullio RA Jr. Kastrinakis NG Levy B Kletsas D Yoneta A Herlyn M Kittas C Halazonetis TD Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 2005, 434(7035):907-913 15829965
46. Smedley D Sidhar S Birdsall S Bennett D Herlyn M Cooper C Shipley J Characterization of chromosome 1 abnormalities in malignant melanomas Genes Chromosomes Cancer 2000, 28(1):121-125 10738310
47. Gillanders E Juo SH Holland EA Jones M Nancarrow D Freas-Lutz D Sood R Park N Faruque M Markey C Kefford RF Palmer J Bergman W Bishop DT Tucker MA Bressac-de Paillerets B Hansson J Stark M Gruis N Bishop JN Goldstein AM Bailey-Wilson JE Mann GJ Hayward N Trent J Localization of a novel melanoma susceptibility locus to 1p22 Am J Hum Genet 2003, 73(2):301-313 1180369 12844286
48. Walker GJ Indsto JO Sood R Faruque MU Hu P Pollock PM Duray P Holland EA Brown K Kefford RF Trent JM Mann GJ Hayward NK Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval Genes Chromosomes Cancer 2004, 41(1):56-64 15236317
49. Oegema K Savoian MS Mitchison TJ Field CM Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis J Cell Biol 2000, 150(3):539-552 10931866
50. Stros M Ozaki T Bacikova A Kageyama H Nakagawara A HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter J Biol Chem 2002, 277(9):7157-7164. 11748232
51. Lasagni L Francalanci M Annunziato F Lazzeri E Giannini S Cosmi L Sagrinati C Mazzinghi B Orlando C Maggi E Marra F Romagnani S Serio M Romagnani P An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 J Exp Med 2003, 197(11):1537-1549. 12782716
52. de Roux N Genin E Carel JC Matsuda F Chaussain JL Milgrom E Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 Proc Natl Acad Sci U S A 2003, 100(19):10972-10976. 196911 12944565
53. Seminara SB Messager S Chatzidaki EE Thresher RR Acierno JS Jr. Shagoury JK Bo-Abbas Y Kuohung W Schwinof KM Hendrick AG Zahn D Dixon J Kaiser UB Slaugenhaupt SA Gusella JF O'Rahilly S Carlton MB Crowley WF Jr. Aparicio SA Colledge WH The GPR54 gene as a regulator of puberty N Engl J Med 2003, 349(17):1614-1627. 14573733
54. Cheung CC Thornton JE Kuijper JL Weigle DS Clifton DK Steiner RA Leptin is a metabolic gate for the onset of puberty in the female rat Endocrinology 1997, 138(2):855-858. 9003028
55. Smith JT Acohido BV Clifton DK Steiner RA KiSS-1 neurones are direct targets for leptin in the ob/ob mouse J Neuroendocrinol 2006, 18(4):298-303. 16503925
56. Bilban M Ghaffari-Tabrizi N Hintermann E Bauer S Molzer S Zoratti C Malli R Sharabi A Hiden U Graier W Knofler M Andreae F Wagner O Quaranta V Desoye G Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts J Cell Sci 2004, 117(Pt 8):1319-1328. 15020672
57. Xu G Guimond MJ Chakraborty C Lala PK Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product Biol Reprod 2002, 67(2):681-689. 12135914
58. Vuillermoz B Khoruzhenko A D'Onofrio MF Ramont L Venteo L Perreau C Antonicelli F Maquart FX Wegrowski Y The small leucine-rich proteoglycan lumican inhibits melanoma progression Exp Cell Res 2004, 296(2):294-306. 15149859
59. Bittner M Meltzer P Chen Y Jiang Y Seftor E Hendrix M Radmacher M Simon R Yakhini Z Ben-Dor A Sampas N Dougherty E Wang E Marincola F Gooden C Lueders J Glatfelter A Pollock P Carpten J Gillanders E Leja D Dietrich K Beaudry C Berens M Alberts D Sondak V Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 2000, 406(6):595-536. 540 10952317
60. Dissanayake SK Wade M Johnson CE O'Connell MP Leotlela PD French AD Shah KV Hewitt KJ Rosenthal DT Indig FE Jiang Y Nickoloff BJ Taub DD Trent JM Moon RT Bittner M Weeraratna AT The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition J Biol Chem 2007, 282(23):17259-17271. 2263117 17426020
61. Kao YR Shih JY Wen WC Ko YP Chen BM Chan YL Chu YW Yang PC Wu CW Roffler SR Tumor-associated antigen L6 and the invasion of human lung cancer cells Clin Cancer Res 2003, 9(7):2807-2816. 12855661
62. Gonzalez AM Gonzales M Herron GS Nagavarapu U Hopkinson SB Tsuruta D Jones JC Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo Proc Natl Acad Sci U S A 2002, 99(25):16075-16080. 138567 12454288
63. French J Stirling R Walsh M Kennedy HD The expression of Ras-GTPase activating protein SH3 domain-binding proteins, G3BPs, in human breast cancers Histochem J 2002, 34(5):223-231. 12587999
64. Fishelson Z Donin N Zell S Schultz S Kirschfink M Obstacles to cancer immunotherapy: Expression of membrane complement regulatory proteins (mCRPs) in tumors Mol Immunol 2003, 40(2-4):109-123. 12914817
65. Philip S Kundu GC Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways J Biol Chem 2003, 278(16):14487-14497. 12473670
66. Ruiter DJ Mattijssen V Broecker EB Ferrone S MHC antigens in human melanomas Semin Cancer Biol 1991, 2(1):35-45. 1912517
67. Weeraratna AT Becker D Carr KM Duray PH Rosenblatt KP Yang S Chen Y Bittner M Strausberg RL Riggins GJ Wagner U Kallioniemi OP Trent JM Morin PJ Meltzer PS Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome Oncogene 2004, 23(12):2264-2274. 14755246
68. Bernsen MR Hakansson L Gustafsson B Krysander L Rettrup B Ruiter D Hakansson A On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases Br J Cancer 2003, 88(3):424-431. 12569387
69. Alonso SR Ortiz P Pollan M Perez-Gomez B Sanchez L Acuna MJ Pajares R Martinez-Tello FJ Hortelano CM Piris MA Rodriguez-Peralto JL Progression in cutaneous malignant melanoma is associated with distinct expression profiles: A tissue microarray-based study Am J Pathol 2004, 164(1):193-203. 1602212 14695333
70. Altomonte M Fonsatti E Visintin A Maio M Targeted therapy of solid malignancies via HLA class II antigens: A new biotherapeutic approach? Oncogene 2003, 22(42):6564-6569. 14528281
71. Mandruzzato S Callegaro A Turcatel G Francescato S Montesco MC Chiarion-Sileni V Mocellin S Rossi CR Bicciato S Wang E Marincola FM Zanovello P A gene expression signature associated with survival in metastatic melanoma J Transl Med 2006, 4:50. 1697826 17129373
72. Piras F Colombari R Minerba L Murtas D Floris C Maxia C Corbu A Perra MT Sirigu P The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase Cancer 2005, 104(6):1246-1254. 16078259
73. van Duinen SG Ruiter DJ Broecker EB van der Velde EA Sorg C Welvaart K Ferrone S Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma Cancer Res 1988, 48(4):1019-1025. 3338074
74. Rangel LB Agarwal R Sherman-Baust CA Mello-Coelho V Pizer ES Ji H Taub DD Morin PJ Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers Cancer Biol Ther 2004, 3(10):1021-1027. 15467430
75. Shy ME Hobson G Jain M Boespflug-Tanguy O Garbern J Sperle K Li W Gow A Rodriguez D Bertini E Mancias P Krajewski K Lewis R Kamholz J Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy Ann Neurol 2003, 53(3):354-365. 12601703
76. Skubitz KM Skubitz AP Differential gene expression in uterine leiomyoma J Lab Clin Med 2003, 141(5):297-308. 12761473
77. Hoek KS Schlegel NC Brafford P Sucker A Ugurel S Kumar R Weber BL Nathanson KL Phillips DJ Herlyn M Schadendorf D Dummer R Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature Pigment Cell Res 2006, 19(4):290-302. 16827748
78. Stolt CC Rehberg S Ader M Lommes P Riethmacher D Schachner M Bartsch U Wegner M Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10 Genes Dev 2002, 16(2):165-170. 155320 11799060
79. Potterf SB Furumura M Dunn KJ Arnheiter H Pavan WJ Transcription factor hierarchy in Waardenburg syndrome: Regulation of MITF expression by SOX10 and PAX3 Hum Genet 2000, 107(1):1-6. 10982026
80. Levy C Khaled M Fisher DE MITF: Master regulator of melanocyte development and melanoma oncogene Trends Mol Med 2006. 16899407
81. Steingrimsson E Copeland NG Jenkins NA Melanocytes and the microphthalmia transcription factor network Annu Rev Genet 2004, 38:365-411. 15568981
82. Loercher AE Tank EM Delston RB Harbour JW MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A J Cell Biol 2005, 168(1):35-40. 2171666 15623583
83. Carreira S Goodall J Aksan I La Rocca SA Galibert MD Denat L Larue L Goding CR Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression Nature 2005, 433(7027):764-769. 15716956
84. Garraway LA Widlund HR Rubin MA Getz G Berger AJ Ramaswamy S Beroukhim R Milner DA Granter SR Du J Lee C Wagner SN Li C Golub TR Rimm DL Meyerson ML Fisher DE Sellers WR Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 2005, 436(7047):117-122. 16001072
85. Du J Widlund HR Horstmann MA Ramaswamy S Ross K Huber WE Nishimura EK Golub TR Fisher DE Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF Cancer Cell 2004, 6(6):565-576. 15607961
86. Busca R Berra E Gaggioli C Khaled M Bille K Marchetti B Thyss R Fitsialos G Larribere L Bertolotto C Virolle T Barbry P Pouyssegur J Ponzio G Ballotti R Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells J Cell Biol 2005, 170(1):49-59. 2171372 15983061
87. McGill GG Haq R Nishimura EK Fisher DE c-Met expression is regulated by Mitf in the melanocyte lineage J Biol Chem 2006, 281(15):10365-10373. 16455654
88. Gaggioli C Robert G Bertolotto C Bailet O Abbe P Spadafora A Bahadoran P Ortonne JP Baron V Ballotti R Tartare-Deckert S Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway J Invest Dermatol 2006. 16960555
89. White JM ADAMs: Modulators of cell-cell and cell-matrix interactions Curr Opin Cell Biol 2003, 15(5):598-606. 14519395
90. Sahoo S Brickley DR Kocherginsky M Conzen SD Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer Eur J Cancer 2005, 41(17):2754-2759. 16246546
91. Chen C Li M Chai H Yang H Fisher WE Yao Q Roles of neuropilins in neuronal development, angiogenesis, and cancers World J Surg 2005, 29(3):271-275. 15696396
92. Hoek K Rimm DL Williams KR Zhao H Ariyan S Lin A Kluger HM Berger AJ Cheng E Trombetta ES Wu T Niinobe M Yoshikawa K Hannigan GE Halaban R Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas Cancer Res 2004, 64(15):5270-5282. 15289333
93. de Souza GA Godoy LM Teixeira VR Otake AH Sabino A Rosa JC Dinarte AR Pinheiro DG Silva WA Jr. Eberlin MN Chammas R Greene LJ Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation Proteomics 2006, 6(5):1460-1470. 16429458
94. Bernard K Litman E Fitzpatrick JL Shellman YG Argast G Polvinen K Everett AD Fukasawa K Norris DA Ahn NG Resing KA Functional proteomic analysis of melanoma progression Cancer Res 2003, 63(20):6716-6725. 14583466